How Healthy Adults Respond to the Nasal Flu Vaccine

Clinical trial NCT07726862 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07726862
Sponsor: University of Alabama at Birmingham
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Mucosal Immune Response to Influenza Vaccination

Start date: 2026-10-01
Primary completion: 2030-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.